Juvenile idiopathic arthritis: current and future treatment options

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2006-02-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14656566.7.4.387PMID 16503811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.

  2005cited by this paper
• A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.

  2005cited by this paper
• Leflunomide or methotrexate for juvenile rheumatoid arthritis.

  2005cited by this paper
• Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.

  2005cited by this paper
• Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis.

  2005cited by this paper
• Etanercept and uveitis in patients with juvenile idiopathic arthritis.

  2005cited by this paper
• Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.

  2005cited by this paper
• Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis.

  2005cited by this paper
• Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

  2005cited by this paper
• CHAPTER 5 – PHARMACOLOGY AND DRUG THERAPY

  2005cited by this paper
• CHAPTER 9 – CHRONIC ARTHRITIS IN CHILDHOOD

  2005cited by this paper
• Intra-articular steroids in pauciarticular juvenile chronic arthritis, type 1

  2005cited by this paper
• Juvenile chronic arthritis: Imaging of the knees and hips before and after intraarticular steroid injection

  2005cited by this paper
• Successfully treated sulphasalazine-Induced fulminant hepatic failure, Thrombocytopenia and Erythroid Hypoplasia with intravenous immunoglobulin

  2005cited by this paper
• Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis.

  2005cited by this paper
• Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score.

  2005cited by this paper
• Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.

  2004cited by this paper
• International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

  2004cited by this paper
• Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study.

  2004cited by this paper
• Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

  2004cited by this paper
• Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.

  2004cited by this paper
• International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

  2004cited by this paper
• A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.

  2004cited by this paper
• Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis.

  2004cited by this paper
• Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial.

  2004cited by this paper
• Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity

  2004cited by this paper
• Adalimumab therapy in rheumatoid arthritis.

  2004cited by this paper
• Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis.

  2003cited by this paper
• Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis

  2003cited by this paper
• Treatment of refractory juvenile idiopathic arthritis via pulse therapy using methylprednisolone and cyclophosphamide

  2003cited by this paper
• Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.

  2003cited by this paper
• Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy.

  2003cited by this paper
• Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.

  2003cited by this paper
• Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis.

  2002cited by this paper
• Sulfasalazine therapy for juvenile rheumatoid arthritis.

  2002cited by this paper
• Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis.

  2002cited by this paper
• Osteoporosis in childhood rheumatic diseases: prevention and therapy.

  2002cited by this paper
• Effects of Intranasal Salmon Calcitonin in Juvenile Idiopathic Arthritis: An Observational Study

  2001cited by this paper
• Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study.

  2001cited by this paper
• Sulfasalazine for the management of juvenile rheumatoid arthritis.

  2001cited by this paper
• Isolated temporomandibular synovitis as unique presentation of juvenile idiopathic arthritis.

  2001cited by this paper
• Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.

  2000cited by this paper
• Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study.

  2000cited by this paper
• High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.

  2000cited by this paper
• Nabumetone induced pseudoporphyria in childhood.

  2000cited by this paper
• Juvenile arthritis - who gets it, where and when? : A review of current data on incidence and prevalence

  1999cited by this paper
• Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

  1999cited by this paper
• Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.

  1999cited by this paper
• Juvenile arthritis--who gets it, where and when? A review of current data on incidence and prevalence.

  1999cited by this paper
• Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial

  1999cited by this paper
• Current treatment by United States and Canadian pediatric rheumatologists.

  1999cited by this paper
• Gastroduodenal lesions in children with juvenile rheumatoid arthritis.

  1999cited by this paper
• Calcium and Vitamin D Therapy in Corticosteroid-Induced Bone Loss: What is the Evidence?

  1999cited by this paper
• Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis.

  1998cited by this paper
• Intraarticular corticosteroid injection in the management of children with chronic arthritis.

  1998cited by this paper
• Facial pain and giant cell arteritis.

  1998cited by this paper
• Hodgkin's disease in a patient with juvenile rheumatoid arthritis taking weekly low dose methotrexate.

  1998cited by this paper
• Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells.

  1998cited by this paper
• Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis.

  1998cited by this paper
• Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group.

  1998cited by this paper
• The use of intravenous pulsed methylprednisolone in the treatment of systemic-onset juvenile chronic arthritis.

  1998cited by this paper
• Intravenous corticosteroids: adverse reactions are more variable than expected in children.

  1998cited by this paper
• Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

  1998cited by this paper
• Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis.

  1997cited by this paper
• The mechanism of action of methotrexate.

  1997cited by this paper
• Transient suppression of endogenous cortisol production after intraarticular steroid therapy for chronic arthritis in children.

  1997cited by this paper
• Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis.

  1997cited by this paper
• Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis.

  1997cited by this paper
• Cyclophosphamide induced water intoxication in a woman with Sjögren's syndrome.

  1997cited by this paper
• Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate.

  1997cited by this paper
• The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis.

  1997cited by this paper
• Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study.

  1996cited by this paper
• Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy

  1996cited by this paper
• Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.

  1996cited by this paper
• Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine.

  1996cited by this paper
• Sulfasalazine therapy for juvenile rheumatoid arthritis.

  1996cited by this paper
• Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy.

  1996cited by this paper
• Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases.

  1996cited by this paper
• Clinically significant gastropathy associated with nonsteroidal antiinflammatory drug use in children with juvenile rheumatoid arthritis.

  1995cited by this paper
• Possible mechanisms of action of methotrexate in patients with rheumatoid arthritis.

  1995cited by this paper
• High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis.

  1995cited by this paper
• Naproxen-induced pseudoporphyria: appearance of new skin lesions after discontinuation of treatment.

  1995cited by this paper
• Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth.

  1995cited by this paper
• Naproxen-induced pseudoporphyria in patients with juvenile rheumatoid arthritis.

  1994cited by this paper
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

  1994cited by this paper
• Thalidomide is an inhibitor of angiogenesis.

  1994cited by this paper
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

  1994cited by this paper
• Deflazacort in juvenile chronic arthritis.

  1993cited by this paper
• Methotrexate in resistant juvenile rheumatoid arthritis

  1993cited by this paper
• The use of non-steroidal anti-inflammatory drugs in paediatric rheumatic diseases.

  1993cited by this paper
• Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.

  1992cited by this paper
• Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis--preliminary results of a longterm study.

  1992cited by this paper
• Toxicity of sulfasalazine in systemic juvenile chronic arthritis.

  1991cited by this paper
• Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.

  1991cited by this paper
• Remodelling the pyramid--a pediatric prospective.

  1990cited by this paper
• Remodelling the pyramid--a pediatric prospective.

  1990cited by this paper
• Naproxen-induced pseudoporphyria: a distinctive photodermatitis.

  1990cited by this paper
• Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone.

  1988cited by this paper
• Pulsed methylprednisolone in active early rheumatoid disease: a dose-ranging study.

  1988cited by this paper
• Triamcinolone into the knee joint in juvenile chronic arthritis.

  1988cited by this paper

• How Safe Are Biological Agents in Pediatric Rheumatology?

  2024cites this paper
• Mesenchymal stromal cells in pediatric disease : pathophysiology and treatment

  2016cites this paper
• Multimodality thoracic imaging of juvenile systemic sclerosis: emphasis on clinical correlation and high-resolution CT of pulmonary fibrosis.

  2015influential citation
• Psoriatic Juvenile Idiopathic Arthritis Associated with Uveitis: A Case Report

  2013cites this paper
• Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses.

  2013cites this paper
• Rational development and utilization of antibody-based therapeutic proteins in pediatrics.

  2013cites this paper
• CAPÍTULO 10 – Uveítis en la edad pediátrica y tratamiento con anti-TNF

  2012cites this paper
• Biologics in children’s autoimmune disorders: efficacy and safety

  2011influential citation
• Pharmacotherapy of Juvenile Idiopathic Arthritis

  2009influential citation
• Juvenile idiopathic arthritis, the Egyptian experience.

  2009cites this paper
• Crohn Disease and Mycobacterial Infection in Children: An Intriguing Relationship

  2009cites this paper
• Применение химерных антител к CD20 на В лимфоцитах у больного тяжелым системным вариантом ювенильного ревматоидного артрита

  2008cites this paper
• Utilisation et compositions pour le traitement de l'arthrite rhumatoïde juvénile

  2007cites this paper
• Опыт применения ритуксимаба у больной с системным вариантом юношеского артрита

  2006cites this paper